Mount Ridley Mines Limited Overview
Mount Ridley Mines is a Perth-based critical-minerals explorer that has pivoted, over roughly twelve months, from a dormant nickel–copper and clay rare-earth explorer into a would-be integrated scandium / heavy rare earth / gallium developer at its 100%-owned Grass Patch Project (formerly the Mount Ridley Project) north-east of Esperance, Western Australia. Its thesis rests on three pillars: (1) a very large, shallow, regolith-hosted, co-located inferred resource base — notably a 946Mt scandium resource the company describes as the largest publicly reported JORC (2012) scandium resource globally, plus 838.7Mt of gallium and 122.5Mt of heavy-rare-earth resources — built mostly by re-assaying historical drill pulps rather than new drilling; (2) a proprietary, patent-pending single-leach hydrometallurgical flowsheet, Selectro™, which recovered ~92% scandium and ~84% average HREE at bench scale; and (3) alignment with Western government efforts to build non-Chinese critical-mineral supply chains. It remains pre-revenue, equity-funded and highly speculative.
Company's own description (paraphrased from FY2026 AR). The company presents itself as a Western Australia–focused critical minerals company spanning heavy rare earths, scandium, gallium and light magnetic rare earths. Its principal activity is exploration for demand-driven critical minerals; its core asset is the Grass Patch Project (HREE, scandium, gallium), with the Weld Range West Project (iron and gold, possibly critical minerals) as a secondary asset. Complementary to the upstream business, management states it is pursuing longer-term downstream pathways — processing and separation of critical minerals for supply into allied markets — including work on scandium–aluminium alloys and advanced manufacturing applications (CSIRO collaboration).
Business model. Mount Ridley is a classic junior exploration company whose value creation is meant to come from (a) growing and de-risking JORC Mineral Resources, (b) proving a metallurgical flowsheet, and (c) eventually monetising either via development (mine + processing plant), sale/joint venture of the asset, or licensing of the Selectro™ process to third parties. Management has explicitly flagged both using Selectro™ at Grass Patch and licensing it to others as potential pathways (August 2026 resource release coverage, Bunbury Herald/Bulls N' Bears).
Revenue model. There is no product, service, subscription or licensing revenue. FY2026 "revenue from continuing operations" of A$56,498 was 100% interest income (FY2026 AR Note 6). Historically, other income has comprised R&D tax incentive refunds (A$999,168 in FY2024; A$224,210 in FY2025; nil in FY2026), dividends on a small listed equity holding (A$24,089 in FY2024 and FY2025), and a realised gain on sale of Tribune Resources shares (A$193,170 in FY2025). Revenue mix: product 0% / service 0% / subscription 0% / licensing 0% / financial income ~100%.
Value-chain position. Upstream exploration (resource definition) with an emerging, aspirational mid-stream position (hydrometallurgy via Selectro™; potential separation/refining via partnerships with ORNL, LLNL, Fraunhofer and CSIRO). No mining, processing, or sales capability exists today.
Customer types and end-markets (prospective, not current). If commercialised, products would be scandium oxide (aerospace and defence Al-Sc alloys, solid oxide fuel cells, additive manufacturing), heavy rare earth oxides (Dy, Tb for permanent magnets; Y and others), light magnet rare earths (Nd, Pr) and gallium (semiconductors, defence electronics). Target buyers would be alloy producers, magnet makers, OEMs and government stockpile programs in "allied" jurisdictions (US, EU, Japan per the August 2026 presentation).
Independent characterisation. Mount Ridley is best understood as an option on (i) scandium market formation outside China and Russia and (ii) proof that very low-grade, clay/saprolite-hosted polymetallic material (about 50 ppm Sc; ~29 ppm Ga; ~889 ppm TREO) can be processed economically in a single circuit. The resource "scale" is real in tonnage terms but entirely Inferred, low-grade, and largely derived from re-interpretation and re-assay of 2014–2022 nickel/copper/REE aircore programs. The Selectro™ data are first-pass, laboratory scale (~90 g aliquots from one 16.8 kg composite of five drill holes). The equity story therefore carries geological, metallurgical, market and funding risk simultaneously.
Strategy
Stated strategic themes (paraphrased from FY2026 AR, August 2026 presentation and releases)
-
Integrated critical minerals company: position Grass Patch as a single, large, multi-commodity system (HREE, Sc, Ga, NdPr) rather than a single-commodity deposit.
-
Capital-efficient resource growth: grow and upgrade resources by re-assaying ~14,000+ remaining historical pulps (from ~70,000m of historical drilling) before spending on new drilling; ~80% of tenure untested.
-
Processing-led value creation: advance Selectro™ from bench to pilot/demonstration scale; flotation/beneficiation ahead of leach; bulk testwork to raise technology readiness level; scoping study with engineering firms.
-
Downstream / ore-to-metal ambition: scandium–aluminium alloys and additive manufacturing (CSIRO), separation science partnerships (ORNL, LLNL, Fraunhofer).
-
Allied-market alignment: supply into US/EU/Japan supply chains; OTCID listing to broaden US investor access.
-
Technology optionality: test Selectro™ chemistry on other deposits and metals; potential licensing.
Initiatives announced in the last 24 months
| Date | Initiative | Type | Target / scope | Status |
|---|---|---|---|---|
| Aug–Oct 2025 | Recapitalisation (placement, entitlement, shortfall) | Funding | Up to A$830k at A$0.002 | Completed (entitlement under-subscribed) |
| 12 Nov 2025 | Tenure consolidation of Grass Patch Complex | Land | >1,069 km² | Completed |
| 25 Nov 2025 | Gravity review: 7 targets over ~33km strike | Exploration | Walk-up drill targets | Pending drilling ("2026" intention) |
| 22 Apr 2026 | Multi-element re-assay program (~3,300 pulps) | Resource growth | Growth + classification upgrades | Phase 1 completed; Phase 2 underway |
| 29 Apr 2026 | Metallurgy leadership (Larder) | Capability | Flowsheet development | Completed |
| 20 May 2026 | Phase 1 metallurgical testwork | Processing | Keith's and Winston's prospects | Completed; led to Selectro™ |
| 7 Jul 2026 | CSIRO Kick-Start scandium alloy program | Downstream R&D | A$104k (A$50k CSIRO) | Underway |
| 17 Jul 2026 | OTCID quotation (MRDMF) | Capital markets | US investors | Completed |
| 12–19 Aug 2026 | Selectro™ results and provisional patent | Technology | IP protection; international filings next | Underway |
| Aug 2026 | ORNL Materials Transfer Agreement; LLNL engagement; Fraunhofer samples | Partnerships | Separation science | Early stage |
| 4 Sep 2026 | A$2.0M placement | Funding | Flotation, bulk testwork, scoping study, resource definition, Selectro™ optimisation | Settled 10–11 Sep 2026 |
| Planned | Scoping study and demonstration plant design | Development | Engineering firm engagement | In discussion |
| Planned | Density testwork to upgrade resource categories | Resource | Move parts of Inferred to Indicated | Underway |
ESG commitments / cost programs: none formally announced (no emissions targets, no cost-out targets). The only environmental claim is that Selectro™ uses reagent recycling and could reduce reagent consumption versus conventional HCl processing (company claim).
Medium-term financial targets / guidance: none provided. The company gives activity timelines only (e.g., the 8 Sep 2026 price-query response referenced Phase 2 re-assay and Selectro™ milestones across October–November 2026).
Products & Services
Mount Ridley sells no products or services. The "portfolio" is a set of mineral inventories and one technology platform. Each is catalogued individually.
Grass Patch Scandium Resource (Blocks 1 & 2)
Description: Shallow, flat-lying, supergene-enriched scandium in alluvium, saprolite and basement over alkali-enriched gabbroic intrusions of the Grass Patch Complex.
- Key specifications (26 Aug 2026 MRE, JORC 2012, Inferred, 25 ppm Sc cut-off): 946.09Mt @ 50.1 ppm Sc (76.8 ppm Sc₂O₃) for 47,357t contained Sc / 72,637t Sc₂O₃. Block 1: 367.45Mt @ 50.3 ppm Sc (18,475t Sc). Block 2: 578.63Mt @ 49.9 ppm Sc (28,882t Sc). By material: saprolite 547.3Mt @ 51.6 ppm; alluvium 141.0Mt @ 49.9 ppm; basement 257.9Mt @ 47.1 ppm. Strike >25km, average width >3.5km (up to 6km), surface to ~70m. Supported by 410 holes / 14,828m (402 aircore, 8 diamond). ID² estimation in Leapfrog; 120 ppm top-cut; densities 1.53/1.61/2.60 t/m³.
Prior version: Maiden MRE 28 Jan 2026 — 367.98Mt @ 57.3 ppm Sc (87.9 ppm Sc₂O₃), 18,855t Sc (FY2026 AR). Discrepancy: regional press reported 57.2 ppm and 18,555t; the Annual Report figure (18,855t) is preferred.
Target customer: Al-Sc alloy producers, SOFC manufacturers, aerospace/defence, additive manufacturing (CSIRO Lab22 program).
Pricing: Not applicable; the August 2026 presentation cited scandium oxide prices above US$2,100/kg (company-sourced).
Grass Patch Heavy Rare Earth Resource (Blocks 1 & 2)
- Key specifications (24 Mar 2026 MRE, Inferred, 300 ppm TREO cut-off): 122.55Mt @ 889 ppm TREO (364 ppm HREO; 525 ppm LREO; 233 ppm MREO) for 108,954t TREO and 44,610t HREO (≈41% of TREO), including ~4,272t Dy₂O₃ and ~719t Tb₄O₇. Block 1 (Central/Keith's): 35.37Mt @ 746 ppm TREO; Block 2 (Northern/Winston): 87.18Mt @ 947 ppm TREO. Strike >15.8km.
Mineralogy: REE confirmed hosted in phosphates (6 Aug 2026 release) — relevant because phosphate-hosted REE are generally less amenable to the mild ammonium-sulphate desorption used for true ionic clays, which helps explain the company's development of a bespoke leach.
Mia Prospect Light/Magnet REE Resource (Block 3)
Key specifications (Inferred, 750 ppm TREO cut-off): 168Mt @ 1,201 ppm TREO; Pr₆O₁₁ 57 ppm, Nd₂O₃ 215 ppm, Tb₄O₇ 4 ppm, Dy₂O₃ 25 ppm; MagREO 301 ppm (25% of TREO). Reported ~2024.
Host: Biranup Complex granitoid gneiss (Albany-Fraser Orogen).
Grass Patch Gallium Resource (Blocks 1–3)
- Key specifications (28 Oct 2025 MRE, Inferred, 25 ppm Ga cut-off): 838.77Mt @ 29.3 ppm Ga (39.5 ppm Ga₂O₃) for 24,584t Ga / 33,045t Ga₂O₃. Block 1: 164.06Mt @ 29.8 ppm (4,888t Ga); Block 2: 372.23Mt @ 30.3 ppm (11,288t Ga); Block 3: 302.4Mt (grade implied by difference; not separately verified here).
Selectro™ Process (technology platform)
| Element | HCl baseline (%) | Selectro Test 1 (%) | Selectro Test 2 (%) | Selectro Test 3 (%) |
|---|---|---|---|---|
| Sc | 27.6 | 62.1 | 80.0 | 92.0 |
| Dy | 39.4 | 54.4 | 77.3 | 85.0 |
| Tb | 45.7 | 62.6 | 83.1 | 83.1 |
| Y | 46.8 | 61.1 | 80.2 | 86.3 |
| — | 30.2 | 55.2 | 75.2 | 81.7 |
| Pr | 30.8 | 48.9 | 73.6 | 81.3 |
| Ga | 0.0 | 57.3 | 55.8 | 41.5 |
Description: Proprietary, single-feed, multi-commodity hydrometallurgical leach intended to recover Sc, HREE, LREE and Ga simultaneously from unbeneficiated Grass Patch material at atmospheric pressure, using lower-cost reagents with recycling in a closed loop (company claims).
- Key results (bench scale, Nagrom Pty Ltd, 16.8kg composite from five historical diamond holes; ~90g aliquots; 24-hour tests):
Source: FY2026 AR Table 1. Test 3 reportedly used approximately half the reagent dose of earlier tests. Gallium recovery fell at the lower dose — a trade-off to watch.
IP status: Provisional patent application lodged 19 Aug 2026; international filings planned.
Launch year: 2026 (first results 12 Aug 2026).
Commercial model: Undecided — own-use at Grass Patch, licensing, or both.
Weld Range West Iron/Gold Project
Description: 52 km² covering ~10km (18%) of the Weld Range BIF sequence near Sinosteel Midwest's Madoonga/Beebyn deposits and Fenix Resources' Iron Ridge.
Key results: 146 rock chips (Jan 2025) up to 62.03% Fe; several >60% Fe (Wilgie Mia and Lulworth units).
Downstream initiatives (pre-commercial)
CSIRO Kick-Start Sc alloy / 3D-printing program: A$104,000 project, A$50,000 CSIRO co-funding (7 Jul 2026).
Oak Ridge National Laboratory: executed Materials Transfer Agreement.
Lawrence Livermore National Laboratory: ongoing engagement (no executed agreement disclosed).
Fraunhofer (Germany): Grass Patch ore samples provided for evaluation.
Financial Narrative
All figures AUD thousands unless stated. Primary source: FY2026 AR (FY2026, FY2025), FY2025 AR (FY2025, FY2024, five-year summary). FY2022–FY2023 cash-flow figures are from aggregators (Stockopedia, TipRanks) and are flagged. Blank cells = not available from verified sources.
Income statement
Notes: (1) The five-year "Revenue" line in the remuneration reports appears to include other income items (R&D refunds, dividends, gains); the statutory "revenue from continuing operations" is lower. Both are shown; the discrepancy is definitional. (2) FY2024 EPS is restated for the December 2024 1-for-10 consolidation in the FY2025 AR; FY2022–FY2023 EPS are as originally reported (pre-consolidation) and are not comparable — multiplying by 10 would give an approximate post-consolidation equivalent (-0.78 and -0.66 cents; analyst adjustment). (3) Gross, operating, EBITDA and net margins are not meaningful (losses are 10–42x revenue). Revenue CAGR is not meaningful for a pre-revenue explorer.
Commentary. The P&L is a cost ledger. FY2023's A$4.65M loss reflected the most intense REE drilling/assay phase; FY2024 fell to A$1.99M as exploration was cut and a near-A$1M R&D refund was booked. FY2025's A$2.64M loss was inflated by the A$1.71M impairment of all capitalised exploration (management cited REE market conditions and inability to confirm future spending). FY2026's A$2.38M loss had a different composition: exploration spending rose only modestly (A$764k), but corporate costs stepped up sharply — directors' fees more than doubled to A$386k (new MD/CEO and chair), administration rose 2.6x to A$452k (advertising/marketing A$153k, travel A$119k, legal A$61k, investor relations A$17k), and A$353k of non-cash share-based payments were recognised. Corporate overhead now rivals or exceeds on-ground exploration, a typical feature of the "promotion" phase of a junior re-rating but one that investors should monitor.
Balance sheet
Sources: FY2025 and FY2026 ARs; FY2022 cash per TipRanks; FY2023 cash and equity per FY2025 AR opening balances; FY2023 PP&E and lease per FY2025 AR notes. Total debt short/long split: nil/nil in every year.
Commentary. The balance sheet is clean but tiny: no debt, no intangible assets, and since the FY2025 impairment, no capitalised exploration. Equity of A$2.0M at 30 June 2026 essentially equals cash. A$41.1M of cumulative paid-in capital against A$41.2M of accumulated losses illustrates two decades of value destruction prior to the 2025–2026 re-rating. Unused tax losses unrecognised as deferred tax assets stood at A$33.6M (FY2026 AR Note 8.5) — potentially valuable only if the company ever becomes taxable and passes continuity tests.
Cash flow
Sources: FY2024–FY2026 from ARs. FY2022–FY2023 from Stockopedia (TipRanks shows OCF of -3,190 and -3,960 respectively — a ~1–2% discrepancy between aggregators).
Commentary. Operating cash burn nearly doubled in FY2026 to A$1.90M as head office costs rose to A$1.16M (versus A$0.64M) and the R&D refund disappeared. FY2025 burn was artificially low because the company was largely dormant and sold its Tribune Resources shares (A$591k). Funding in FY2026 came from a sequence of small raisings at A$0.002 (placement, entitlement, shortfall, related-party issue), option exercises at A$0.01–A$0.03, and a A$1.26M underwriting at A$0.03 in January 2026 — total gross equity of A$3.06M (FY2026 AR Note 15). After year-end, the A$2.0M placement at A$0.033 (6% fee; directors to add A$100k subject to approval) brings pro-forma cash to roughly A$3.7M before Q1 FY2027 burn (analyst calculation: A$1.886M + ~A$1.88M net). At the FY2026 average burn of ~A$0.48M per quarter, that implies roughly 7–8 quarters of runway; however, the stated program (bulk metallurgical testwork, flotation, scoping study, Phase 2 re-assays, international patents, demonstration-plant planning) points to a materially higher burn, so a further raise within 12 months is likely (analyst judgement).
Ratios
ROIC, net debt/EBITDA, interest coverage, asset turnover and cash conversion cycle are not meaningful (no revenue, no debt, no inventory/receivables cycle).
Inflections. The key inflection is not in the accounts but in the market value: equity of ~A$2M versus a market capitalisation of ~A$45–50M implies the market is pricing ~A$43–48M of value for the resources and Selectro™ IP that carry zero book value after the FY2025 impairment.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Ownership | Function | Source |
|---|---|---|---|
Mount Ridley Mines Limited | Listed parent | Holds tenements (E63/1547, E63/1564, E63/2111, E63/2112 and others), head of tax-consolidated group | FY2025 AR; JORC Table 1 |
Bepary Pty Ltd | 100% | Dormant, no assets/liabilities | FY2025 AR Note 29 |
Mount Ridley Tech Pty Ltd | 100% | Holds Selectro™ intellectual property and patent application | 19 Aug 2026 release |
Revenue by Segment and Revenue by Segment (%)
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Mineral exploration segment revenue from continuing operations (AUD K) | 87.5 | 229.0 | 56.5 |
Mineral exploration segment loss before tax (AUD K) | -1,985.4 | -2,644.5 | -2,378.5 |
Segment share of Group revenue (%) | 100 | 100 | 100 |
Segment revenue YoY growth (%) | — | 161.7 | -75.3 |
Project Portfolio
| Project | Location | Commodities | Status | FY2026 relevance |
|---|---|---|---|---|
Grass Patch Project (formerly Mount Ridley Project) — Blocks 1A/1B, 2, 3 (Mia) | ~25km N/NE of Esperance, WA (company's 2026 framing); >1,069 km² | Sc, HREE (Dy, Tb, Y), Ga, NdPr | Inferred resources; metallurgical testwork; scoping study discussions | Flagship; nearly all expenditure |
Selectro™ Process (technology) | IP in Mount Ridley Tech Pty Ltd | Hydrometallurgy for Sc/REE/Ga | Bench scale; provisional patent | Core value driver from Aug 2026 |
Weld Range West Project | Murchison, Mid-West WA; 52 km² | Iron (BIF hematite), gold; possible critical minerals | Reconnaissance rock-chips (up to 62.03% Fe) | Non-core |
Income Statement
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue per AR five-year summary (AUD K) | 48.4 | 708.1 | 1,270.1 | 284.1 | 56.5 |
Revenue from continuing operations per income statement (AUD K) | — | — | 87.5 | 229.0 | 56.5 |
R&D tax incentive income (AUD K) | — | — | 999.2 | 224.2 | 0 |
Exploration expenditure expensed (AUD K) | — | — | 2,403.6 | 556.5 | 763.7 |
Exploration asset impairment (AUD K) | — | — | 0 | 1,710.0 | 0 |
Directors' fees (AUD K) | — | — | 156.2 | 174.7 | 385.8 |
Share-based payments expense (AUD K) | — | — | -147.3 | 0 | 353.2 |
Administration expenses (AUD K) | — | — | 271.1 | 176.6 | 452.4 |
Consulting expenses (AUD K) | — | — | 217.2 | 238.4 | 252.6 |
Compliance and regulatory (AUD K) | — | — | 76.6 | 141.0 | 180.1 |
Depreciation (AUD K) | — | — | 84.8 | 50.7 | 20.0 |
Operating income per StockAnalysis aggregator (AUD K) | -2,830 | -4,370 | -1,930 | -2,470 | — |
EBITDA analyst calc = pre-tax loss + depreciation (AUD K) | — | — | -1,900.5 | -2,593.8 | -2,358.5 |
Pre-tax loss (AUD K) | -4,312.3 | -4,647.1 | -1,985.4 | -2,644.5 | -2,378.5 |
Net loss after tax (AUD K) | -4,312.3 | -4,647.1 | -1,985.4 | -2,644.5 | -2,378.5 |
Basic and diluted EPS as reported (cents; FY2022-FY2023 pre-consolidation basis) | -0.078 | -0.066 | -0.26 | -0.34 | -0.20 |
Dividends per share (cents) | 0 | 0 | 0 | 0 | 0 |
Weighted average shares (millions; post-consolidation basis) | — | — | 778.5 | 778.5 | 1,166.2 |
Balance Sheet
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (AUD K) | — | — | 3,964.2 | 1,209.8 | 2,174.6 |
Cash and equivalents (AUD K) | 2,260 | 3,470.3 | 1,391.6 | 949.6 | 1,885.8 |
Listed investments at fair value (AUD K) | — | — | 397.5 | 0 | 0 |
Capitalised exploration and evaluation (AUD K) | — | 1,949.5 | 1,710.0 | 0 | 0 |
Property plant and equipment (AUD K) | — | 386.3 | 275.2 | 205.7 | 195.1 |
Total borrowings (AUD K) | 0 | 0 | 0 | 0 | 0 |
Lease liabilities (AUD K) | — | 57.4 | 24.2 | 0 | 0 |
Net debt negative means net cash (AUD K) | -2,260 | -3,412.9 | -1,367.4 | -949.6 | -1,885.8 |
Total liabilities (AUD K) | — | — | 162.1 | 52.2 | 176.5 |
Total equity (AUD K) | — | 5,934.7 | 3,802.0 | 1,157.6 | 1,998.1 |
Issued capital (AUD K) | — | 38,196.6 | 38,196.6 | 38,196.6 | 41,127.9 |
Accumulated losses (AUD K) | — | -34,239.5 | -36,224.8 | -38,869.3 | -41,247.8 |
Working capital (AUD K) | — | — | 1,772.8 | 951.9 | 1,803.0 |
Goodwill and intangibles (AUD K) | 0 | 0 | 0 | 0 | 0 |
Ordinary shares on issue period end (millions; post-consolidation basis) | — | — | 778.5 | 778.5 | 1,328.4 |
Cash Flow
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating cash flow (AUD K) | -3,240 | -3,990 | -2,047.8 | -1,015.7 | -1,902.9 |
Of which payments for exploration and evaluation (AUD K) | — | — | -2,549.7 | -640.5 | -802.7 |
Of which payments to suppliers and employees (AUD K) | — | — | -574.3 | -635.2 | -1,156.7 |
R&D refund received (AUD K) | — | — | 999.2 | 224.2 | 0 |
Capex on PP&E (AUD K) | -269 | -216 | 0 | -1.0 | -10.3 |
Free cash flow analyst calc OCF plus capex (AUD K) | -3,509 | -4,206 | -2,047.8 | -1,016.7 | -1,913.2 |
Investing cash flow (AUD K) | 349 | -253 | 5.0 | 598.5 | -16.5 |
Financing cash flow (AUD K) | 3,710 | 5,450 | -35.9 | -24.8 | 2,855.6 |
Gross proceeds from share and option issues (AUD K) | — | — | 0 | 0 | 2,997.0 |
Dividends paid (AUD K) | 0 | 0 | 0 | 0 | 0 |
Share buybacks (AUD K) | 0 | 0 | 0 | 0 | 0 |
Net change in cash (AUD K) | 814 | 1,210 | -2,078.7 | -442.0 | 936.2 |
Margin Analysis (%) and Financial Ratios (x)
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
ROE analyst calc on average equity (%) | -40.8 | -106.6 | -150.7 |
ROA analyst calc on average assets (%) | — | -102.2 | -140.5 |
Current ratio (x) | 11.9 | 19.2 | 11.2 |
Debt to equity (x) | 0 | 0 | 0 |
Cash as share of total assets (%) | 35.1 | 78.5 | 86.7 |
Operating cash burn to opening cash (%) | 59.0 | 73.0 | 200.4 |
Revenue by Region
| Region | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Australia revenue from continuing operations (AUD K) | 87.5 | 229.0 | 56.5 |
Americas revenue (AUD K) | 0 | 0 | 0 |
EMEA revenue (AUD K) | 0 | 0 | 0 |
APAC excluding Australia revenue (AUD K) | 0 | 0 | 0 |
Share Price
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Share price at start of year as reported (AUD) | 0.002 | 0.005 | 0.002 | 0.001 | 0.002 |
Share price at end of year as reported (AUD) | 0.005 | 0.002 | 0.001 | 0.002 | 0.021 |
Valuation Snapshot
| Metric | Value | Basis |
|---|---|---|
Market capitalisation | ~A$48.6M | ~1.389bn shares × A$0.035 |
Pro-forma cash | ~A$3.7M | A$1.886M (30 Jun 2026) + ~A$1.88M net placement, before Q1 FY2027 burn |
Enterprise value | ~A$44.9M | Mkt cap − cash; no debt |
EV per tonne contained Sc | ~A$948/t Sc | A$44.9M / 47,357t |
EV per tonne contained HREO | ~A$1,006/t HREO | A$44.9M / 44,610t (not additive with Sc metric) |
P/B | ~24x on 30 Jun 2026 equity; ~12x pro forma | A$48.6M / A$2.0M; / ~A$3.9M |
P/E, EV/EBITDA, EV/Sales | Not meaningful (losses; no sales) | — |
Capital Markets
| Item | Status |
|---|---|
Analyst consensus | None (no broker coverage) |
Dividend history / policy | No dividends ever paid; none expected |
Credit ratings (Moody's/S&P/Fitch) | Not rated |
Debt maturity profile | No debt |
Recent equity issues | Aug–Oct 2025 at A$0.002; Jan 2026 underwriting at A$0.03; Sep 2026 placement at A$0.033 |
Options / rights overhang | 476.2M options @ A$0.01 to Sep 2030; 67.6M performance rights |
Dual listing | OTCID (MRDMF) from 17 Jul 2026 |
Analyst Conclusions
Management guidance. No financial guidance. Operational priorities (FY2026 AR; 26 Aug and 4 Sep 2026 releases): flotation testwork to validate TIMA findings and then Selectro™ leach on beneficiated ore; bulk metallurgical testwork to raise technology readiness; Selectro™ trials on other deposits and metals; density testwork to upgrade resource categories; scoping-study engagement for a demonstration plant; Phase 2 re-assay program; international patent filings; continued work with ORNL, LLNL, Fraunhofer and CSIRO; drilling of walk-up targets "planned for 2026".
Consensus growth expectations. None — no analyst forecasts exist.
Bull case (grounded in data above).
-
Resource leverage at low cost: Contained Sc rose ~2.5x in seven months through re-assays alone; with ~14,000 pulps left and ~80% of tenure untested, further low-cost growth is plausible, and an Indicated upgrade would materially de-risk the asset.
-
Process differentiation: If Selectro™'s ~92% Sc / ~84% HREE recoveries at atmospheric pressure hold at bulk scale and on beneficiated feed, the low grade becomes less of a handicap, and the IP could carry standalone licensing value.
-
Policy tailwind: The US OSC's conditional US$400M commitment to a peer shows Western governments will finance scandium supply; MRD's tonnage, US lab links and OTC quotation position it to compete for similar support.
Bear case.
-
Grade and scale economics: ~50 ppm Sc and ~29 ppm Ga imply very large throughput; no scoping-level economics exist, and the resource is entirely Inferred with limited density data.
-
Bench-to-plant gap: Results come from ~90g aliquots of a single composite; gallium recovery already deteriorated at lower reagent dose; many promising leach technologies fail during scale-up.
-
Funding and dilution: Cash burn doubled in FY2026, corporate overhead is rising faster than exploration spend, and >540M options and rights overhang a ~1.39bn share base; a demonstration plant will require far more capital than the A$2M just raised.
Key catalysts and monitorables (next 12 months).
Concluding analyst verdict.
Mount Ridley Mines has undergone one of the sharper re-ratings among ASX critical-mineral juniors over the past year. It moved from a near-dormant shell that raised money at A$0.002 in August 2025 with a going-concern warning, to a ~A$45–50M company. Today it claims the world's largest publicly reported JORC scandium resource, alongside large gallium and heavy-rare-earth inventories and a patent-pending single-leach process. The transformation was achieved cheaply and creatively. Management mined its own historical database, re-assayed stored pulps, and pivoted the narrative toward processing, where Western supply chains are weakest. The new board and executive team — a capital-markets chair, a geologist-CEO with critical-minerals experience, and a seasoned metallurgist as CTO — are better suited to this phase than their predecessors.
The evidence base, however, remains thin in the places that matter most for value. The resources are all Inferred, low-grade and estimated with limited density control. The metallurgical results come from bench tests on a single composite. The company has no economic study, no offtake, no government funding beyond a A$50k CSIRO grant, and a balance sheet that will not support the demonstration-plant pathway without significant further dilution. FY2026 also showed corporate costs growing faster than on-ground work.
On balance, MRD is a high-risk, high-optionality speculation rather than an investable development story in the institutional sense. The current valuation (~A$950 of EV per tonne of contained scandium) prices in meaningful success for Selectro™ and the scandium market. The next 6–12 months should bring bulk-scale/beneficiated Selectro™ results, an Indicated resource and first-pass scoping economics. These outcomes will determine whether the story converges toward a fundable project or reverts toward a resource-in-search-of-a-market. Position sizing, if any, should reflect binary technical outcomes, ongoing dilution, and the absence of independent research coverage.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Title | Appointed | Background | FY2026 total remuneration (AUD) |
|---|---|---|---|---|
David Wall, BCom (UWA), MAICD | Non-Executive Chairman | 11 Mar 2026 | 20+ years ECM/corporate advisory; Executive Director, GBA Capital; ex-Principal Inyati Capital; ex-MD 88 Energy (2014–2021); energy analyst at Hartleys and Argonaut; corporate strategy at Woodside | 24,000 (part-year; incl. 6,000 unpaid fees) |
Allister Caird, BSc (Hons), GAICD | Managing Director & CEO | CEO 3 Nov 2025; MD 11 Mar 2026 | Geologist, 15+ years; prior roles at CSIRO, Locksley Resources (Head of Critical Minerals), SLB and 88 Energy (Alaska wells incl. two discoveries); director of Australian Critical Minerals Ltd (since Nov 2025) | 445,543 (salary 159,557; unpaid 28,000; super 22,507; performance rights 235,479; 53% performance-related) |
Peter Christie, BBus | Non-Executive Director (Chairman Oct 2018 – Mar 2026) | 8 Oct 2018 | Accountant and tax agent, 26+ years public practice; director of Moho Resources and Patrys | 60,000 |
Kieran Witt, CA, BCom | Non-Executive Director and Company Secretary | 11 Nov 2024 | Chartered Accountant; CoSec for multiple ASX juniors (Mantle Minerals, Western Yilgarn, Patrys, Iron Bear Resources); CFO/CoSec Burley Minerals | 51,500 (incl. 3,500 consulting) |
Chris Larder, FAusIMM | Chief Technology Officer | Technical Advisor 29 Apr 2026; CTO 22 Jul 2026 | 30+ years mineral processing and flowsheet design incl. REE and gallium; Competent Person for metallurgy | Not a KMP in FY2026 table; 24M performance rights issued 23 Jul 2026 |
Pedro Kastellorizos, BSc, MAusIMM | Technical Advisor (NED 2 Apr 2025 – 11 Mar 2026) | — | Geologist, 28+ years; founder Genesis Resources; ex-MD/CEO Argent Minerals; Competent Person for exploration results | 263,207 (incl. 112,000 consulting; 117,740 performance rights) |
Directors' Remuneration
| Attribute | Detail |
|---|---|
Board size | 4 (1 executive, 3 non-executive) |
Chair / CEO separation | Yes — separate since 11 Mar 2026 |
Independence (analyst assessment against ASX Principles) | Christie: long-tenured former chair (8 years) — independence arguable. Witt: also Company Secretary — generally not regarded as independent. Majority independence therefore doubtful. |
Committees | Not disclosed in the Annual Report. Boards of this size commonly perform audit/remuneration functions at full-board level. |
Meetings FY2026 | 3 board meetings + 8 circular resolutions; Wall attended 1 of 3, Caird 2 of 3 |
Gender diversity | 0 of 4 directors female; 0 of disclosed executives female |
Say-on-pay | First strike at Nov 2024 AGM; no second strike at Nov 2025 AGM (<25% against) |
Remuneration consultant | None engaged |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
1 Sep 2024 | Brett Mitchell appointed NED | Capital-markets capability; departed at Nov 2024 AGM |
11 Nov 2024 | Le Page, S. Mitchell, B. Mitchell exit; Clifton, Witt in; Busing replaced as CoSec | Post first-strike AGM board reset |
2 Apr 2025 | Clifton out; Kastellorizos in | Technical (geology) capability |
3 Nov 2025 | Caird appointed CEO | Coincided with gallium resource re-rating |
11 Mar 2026 | Wall Chair; Caird MD; Christie to NED; Kastellorizos to advisor | Professionalisation of board for capital markets |
29 Apr / 22 Jul 2026 | Larder Technical Advisor then CTO | Pivot to metallurgy/Selectro™ |
Major Shareholders
| Holder | Shares | Other securities | Source |
|---|---|---|---|
Kieran Witt | 20,000,000 | 10,000,000 options | FY2026 AR |
Peter Christie | 13,971,944 | 6,000,000 performance rights; 5,499,268 options | FY2026 AR |
David Wall | 6,000,000 | — | FY2026 AR (Market Index shows a 4.7M/1.3M split, consistent with direct/indirect holdings) |
Allister Caird | 0 | 20,000,000 performance rights (Class E/F; 10M vested at 30 Jun 2026) | FY2026 AR |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Ticker / HQ | Relevance | Relative positioning vs MRD |
|---|---|---|---|---|
Scandium | Sunrise Energy Metals (Syerston Scandium Project, NSW) | ASX: SRL | US Department of War Office of Strategic Capital US$400M conditional loan commitment (7 Aug 2026, as cited in MRD's release) | Far more advanced (feasibility-stage, higher grade, autoclave route); MRD claims larger tonnage at much lower grade |
Scandium | Rio Tinto (scandium oxide from Sorel-Tracy, Québec waste streams) | ASX/LSE: RIO | One of the few Western producers | Producer scale; by-product cost advantage |
Scandium | Scandium International Mining (Nyngan Project, NSW) | TSX listed (status to verify) | Permitted Australian project (historically) | Higher grade, smaller tonnage |
Scandium | Scandium Canada (Crater Lake, Québec) | TSXV | Commissioned the EY-Parthenon market outlook MRD cites | Similar development-stage peer |
Scandium | Australian Mines (Flemington, NSW) | ASX: AUZ (status to verify) | Australian lateritic Sc peer | Smaller, earlier-stage |
HREE / clay REE | Lynas Rare Earths | ASX: LYC | Only scaled non-China separated REE producer incl. heavy separation ambitions; potential customer/competitor for feed | Dominant incumbent |
HREE / REE | Iluka Resources (Eneabba refinery) | ASX: ILU | Government-backed refinery seeking third-party feed | Potential customer for MRD concentrate/MREC |
HREE / clay REE | Ionic Rare Earths | ASX: IXR | Ionic-clay and recycling/refining technology peer | More advanced in refining; different jurisdiction (Uganda/UK/Brazil) |
HREE / clay REE | Meteoric Resources (Caldeira, Brazil) | ASX: MEI | High-grade ionic clay | Much higher grade |
HREE / clay REE | Brazilian Rare Earths | ASX: BRE | High-grade Brazilian REE | Much higher grade, larger market cap |
HREE + Sc (WA) | Victory Metals (North Stanmore, WA) | ASX: VTM | WA clay-hosted HREE with scandium credits | Direct WA peer for investor capital |
Clay REE (Esperance region) | OD6 Metals (Splinter Rock) | ASX: OD6 | Same district clay REE | Direct regional peer |
Gallium | China (state-linked producers) | — | ~98% of global primary gallium | Export controls create opportunity for Western supply |
Competitor Detail
| Metric | Mount Ridley (MRD) |
|---|---|
Revenue FY2026 (AUD K) | 56.5 (interest) |
Net loss FY2026 (AUD K) | -2,378.5 |
Cash at 30 Jun 2026 (AUD K) | 1,885.8 |
Headline Sc resource | 946Mt @ 50.1 ppm Sc (Inferred) |
Development stage | Inferred resource; bench metallurgy |



